At three years of EYLEA HD treatment, the vast majority of patients maintained visual and anatomic improvements while achieving extended dosing regimens, including those of just twice a year: 77%, 58% ...
Hemodialysis (HD) patients have a greater risk of dying on the day following a long (two-day) interdialytic interval compared with other days, a study found. Most HD patients do not dialyze in the two ...
88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual and anatomic improvements achieved in the first 96 weeks, in this extension study of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results